tiprankstipranks
Trending News
More News >
Mesoblast Limited (MEOBF)
OTHER OTC:MEOBF

Mesoblast Limited (MEOBF) Stock Statistics & Valuation Metrics

Compare
66 Followers

Total Valuation

Mesoblast Limited has a market cap or net worth of $1.55B. The enterprise value is $713.46M.
Market Cap$1.55B
Enterprise Value$713.46M

Share Statistics

Mesoblast Limited has 1,277,782,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,277,782,200
Owned by Insiders20.41%
Owned by Institutions0.01%

Financial Efficiency

Mesoblast Limited’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -13.77%.
Return on Equity (ROE)-0.18
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-13.77%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee80.85K
Profits Per Employee-1.20M
Employee Count73
Asset Turnover<0.01
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Mesoblast Limited is -7.47. Mesoblast Limited’s PEG ratio is -0.04.
PE Ratio-7.47
PS Ratio0.00
PB Ratio1.05
Price to Fair Value1.37
Price to FCF-8.70
Price to Operating Cash Flow-8.75
PEG Ratio-0.04

Income Statement

In the last 12 months, Mesoblast Limited had revenue of 5.90M and earned -87.96M in profits. Earnings per share was -0.09.
Revenue5.90M
Gross Profit-35.17M
Operating Income-84.15M
Pretax Income-88.15M
Net Income-87.96M
EBITDA-56.08M
Earnings Per Share (EPS)-0.09

Cash Flow

In the last 12 months, operating cash flow was -20.66M and capital expenditures -233.00K, giving a free cash flow of -21.07M billion.
Operating Cash Flow-20.66M
Free Cash Flow-21.07M
Free Cash Flow per Share-0.02

Dividends & Yields

Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.74
52-Week Price Change100.00%
50-Day Moving Average1.43
200-Day Moving Average1.41
Relative Strength Index (RSI)48.85
Average Volume (3m)152.00

Important Dates

Mesoblast Limited upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMay 28, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date

Financial Position

Mesoblast Limited as a current ratio of 1.18, with Debt / Equity ratio of 16.90%
Current Ratio1.18
Quick Ratio1.18
Debt to Market Cap0.17
Net Debt to EBITDA-1.01
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Mesoblast Limited has paid 191.00K in taxes.
Income Tax191.00K
Effective Tax Rate>-0.01

Enterprise Valuation

Mesoblast Limited EV to EBITDA ratio is -12.72, with an EV/FCF ratio of -14.62.
EV to Sales120.89
EV to EBITDA-12.72
EV to Free Cash Flow-14.62
EV to Operating Cash Flow-14.72

Balance Sheet

Mesoblast Limited has $38.03M in cash and marketable securities with $126.11M in debt, giving a net cash position of $88.08M billion.
Cash & Marketable Securities$38.03M
Total Debt$126.11M
Net Cash$88.08M
Net Cash Per Share$0.07
Tangible Book Value Per Share-$0.10

Margins

Gross margin is -349.55%, with operating margin of -1425.74%, and net profit margin of -1490.27%.
Gross Margin-349.55%
Operating Margin-1425.74%
Pretax Margin-1493.51%
Net Profit Margin-1490.27%
EBITDA Margin-950.14%
EBIT Margin-982.24%

Analyst Forecast

The average price target for Mesoblast Limited is $2.21, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.21
Price Target Upside53.47% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score7
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis